MichaelANovakMD

PubMed

• 7 citations
  Switching to brolucizumab: injection intervals and visual, anatomical and safety outcomes at 12 and 18 months in real-world eyes with neovascular age-related macular d...
  Joseph M Coney, Ryan Zubricky, Samriddhi Buxy Sinha, Nina Sonbolian, Lujia Zhou, Thomas P Hull, Shawn A Lewis, David G Miller, Michael A Novak, Scott D Pendergast, Han...> ;International Journal of Retina and Vitreous. 2023 Feb 1
• One-Year and 18-Month Outcomes in nAMD Patient Eyes Switched to Brolucizumab Alone versus to Brolucizumab Alternating with Other Anti-VEGF Agents.
  Coney, J., McCoy, J., Buxy Sinha, S., Sonbolian, N., Zhou, L., Hull, T., Lewis, S., Miller, D., Novak, M., Pendergast, S., Pham, H., Platt, S., Rao, L., Schartman, J.,...> ;Clinical Ophthalmology. 2023 Jan 1

Journal Articles

• VEGFA and VEGFR2 gene polymorphisms and response to anti-vascular endothelial growth factor therapy: comparison of age-related macular degeneration treatments trials (...  
  Hagstrom SA, Ying GS, Pauer GJ, Sturgill-Short GM, Huang J, Maguire MG, Martin DF; Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) Research Group, JAMA Ophthalmol, 1/1/2014
• Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial  
  Age-Related Eye Disease Study 2 Research Group, JAMA, 5/15/2013
• Incidence of choroidal neovascularization in the fellow eye in the comparison of age-related macular degeneration treatments trials  
  Maguire MG, Daniel E, Shah AR, Grunwald JE, et al; Comparison of Age-Related Macular Degeneration Treatments Trials (CATT Research Group), Ophthalmology, 1/1/2013
• Macular morphology and visual acuity in the comparison of age-related macular degeneration treatments trials  
  Jaffe GJ, Martin DF, Toth CA,et al; Comparison of Age-related Macular Degeneration Treatments Trials Research Group, Ophthalmology, 1/1/2013
• Nine loci for ocular axial length identified through genome-wide association studies, including shared loci with refractive error  
  Cheng CY, Schache M, Ikram MK, et al; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions, and Complications Research Group, Am J Hum Genet, 1/1/2013
• Exploratory analysis of the effect of intravitreal ranibizumab or triamcinolone on worsening of diabetic retinopathy in a randomized clinical trial  
  Bressler SB, Qin H, Melia M, et al; Diabetic Retinopathy Clinical Research Network, JAMA Ophthalmol, 1/1/2013
• Methods and reproducibility of grading optimized digital color fundus photographs in the Age-Related Eye Disease Study 2 (AREDS2 Report Number 2)  
  Danis RP, Domalpally A, Chew EY, et al; AREDS2 Study Group, Invest Ophthalmol Vis Sci, 1/1/2013
• Genome-wide meta-analyses of multiancestry cohorts identify multiple new susceptibility loci for refractive error and myopia  
  Verhoeven VJ, Hysi PG, Wojciechowski R,et al; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Research Group, Nat Genet, 1/1/2013
• Pharmacogenetics for genes associated with age-related macular degeneration in the Comparison of AMD Treatments Trials (CATT)  
  Hagstrom SA, Ying GS, Pauer GJ, et al; Comparison of AMD Treatments Trials Research Group, Ophthalmology, 1/1/2013
• Randomized clinical trial evaluating intravitreal ranibizumab or saline for vitreous hemorrhage from proliferative diabetic retinopathy  
  Diabetic Retinopathy Clinical Research Network, JAMA Ophthalmol, 1/1/2013
• Is indocyanine green angiography useful for the diagnosis of macular telangiectasia type 2?  
  Niskopoulou M, Balaskas K, Leung I, Sallo FB, Clemons TE, Bird AC, Peto T; MacTel Study group, Br J Ophthalmol, 1/1/2013
• Baseline predictors for one-year visual outcomes with ranibizumab or bevacizumab for neovascular age-related macular degeneration  
  Ying GS, Huang J, Maguire MG, et al; Comparison of Age-related Macular Degeneration Treatments Trials Research Group, Ophthalmology, 1/1/2013
• Medical Characteristics of Patients with Macular Telangiectasia Type 2 (MacTel Type 2) MacTel Project Report No 3  
  Clemons TE, Gillies MC, Chew EY, Bird AC, Peto T, Wang JJ, Mitchell P, Ramdas WD, Vingerling JR, Macular Telangiectasia Project Research Group, Ophthalmic Epidemiology, 1/1/2013
• The IS/OS junction layer in the natural history of type 2 idiopathic macular telangiectasia  
  Sallo FB, Peto T, Egan C, Wolf-Schnurrbusch UE, Clemons TE, Gillies MC, Pauleikhoff D, Rubin GS, Chew EY, Bird AC; MacTel Study Group, Invest Ophthalmol Vis Sci, 1/1/2012
• “En face” OCT imaging of the IS/OS junction line in type 2 idiopathic macular telangiectasia  
  Sallo FB, Peto T, Egan C, Wolf-Schnurrbusch UE, Clemons TE, Gillies MC, Pauleikhoff D, Rubin GS, Chew EY, Bird AC; MacTel Study Group, Invest Ophthalmol Vis Sci, 1/1/2012
• Intravitreal ranibizumab for diabetic macular edema with prompt versus deferredlaser treatment: three-year randomized trial results  
  Diabetic Retinopathy Clinical Research Network, Elman MJ, Qin H, Aiello LP, Beck RW, Bressler NM, Ferris FL 3rd, Glassman AR, Maturi RK, Melia M., Ophthalmology, 1/1/2012
• Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results  
  Comparison of Age-related Macular Degeneration Treatments Trials (CATT) Research Group, Martin DF, Maguire MG, Fine SL, Ying GS, Jaffe GJ, Grunwald JE, Toth C, Redford..., Ophthalmology, 1/1/2012
• Ranibizumab and bevacizumab for neovascular age-related macular degeneration  
  CATT Research Group, Martin DF, Maguire MG, Ying GS, Grunwald JE, Fine SL, Jaffe GJ, N Engl J Med, 5/19/2011
• Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion twelve-month study results  
  Haller JA, Bandello F, Belfort R Jr, et al; Ozurdex GENEVA Study Group, Li J, Ophthalmology, 1/1/2011
• Retinal crystals in type 2 idiopathic macular telangiectasia  
  Sallo FB, Leung I, Chung M, Wolf-Schnurrbusch UE, Dubra A, Williams DR, Clemons T, Pauleikhoff D, Bird AC, Peto T; MacTel Study Group, Ophthalmology, 1/1/2011
• SCORE Study Report #11 Incidences of neovascular events in eyes with retinal vein occlusion  
  Chan CK, Ip MS, Vanveldhuisen PC, Oden NL, Scott IU, Tolentino MJ, Blodi BA; SCORE Study Investigator Group, Ophthalmology, 1/1/2011
• Expanded 2-year follow-up of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema  
  Diabetic Retinopathy Clinical Research Network; Writing Committee, Elman MJ, Bressler NM, Qin H, Beck RW, Ferris FL 3rd, Friedman SM, Glassman AR, Scott IU, Stockdale ..., Ophthalmology, 1/1/2011
• Factors associated with visual acuity outcomes after vitrectomy for diabetic macular edema: Diabetic Retinopathy Clinical Research Network  
  Flaxel CJ, Edwards AR, Aiello LP, Arrigg PG, Beck RW, Bressler NM, Bressler SB, Ferris FL 3rd, Gupta SK, Haller JA, Lazarus HS, Qin H, Retina, 1/1/2010
• Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion  
  Haller JA, Bandello F, Belfort R Jr, Blumenkranz MS, Gillies M, Heier J, Loewenstein A, Yoon YH, Jacques ML, Jiao J, Li XY, Whitcup SM; OZURDEX GENEVA Study Group, Ophthalmology, 1/1/2010
• Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema  
  Diabetic Retinopathy Clinical Research Network, Ophthalmology, 1/1/2010
• Join now to see all

Books/Book Chapters

• Current Techniques in Ophthalmic Laser Surgery 
  Chapter: Lasers in vitreous surgery. 
  Page 153 - 164Pendergast SD, Zakov ZN, Novak MAEditors: Singerman LJ, Coscas G.Current Medicine, Philadelphia, PA1999
• Management and Care of the Cataract Patient 
  Chapter: The realities of endophthalmitis. 
  Novak MA, Rice TAEditors: Weinstock FJ.Blackwell Scientific Publications, Inc., Boston, MA1992
• Laser Photocoagulation of the Macula 
  Chapter: Subretinal neovascularization. 
  Page 27 - 46Singerman LJ, Novak MAEditors: Yannuzzi LA.JB Lippincott Company, Philadelphia, PA1989
• Acta: XXIV International Congress of Ophthalmology 
  Chapter: Specular microscopy of Schnyder central crystalline dystrophy of the cornea. 
  Page 286 - 289Novak MA, Hirst LWEditors: Henkind P.JB Lippincott Company, Philadelphia, PA1983
• Join now to see all

Abstracts/Posters

• Impact of Lucentis on psychological morbidity in patients with macular edema and neovascularization secondary to retinal vein occlusion.
  Singerman LJ, Himmelman DR, Singerman B, Thomas A, Newman L, Coney JM, Schartman JP, Novak MA, Program#/Poster# 5466/A662. Association for Research in Vision and Ophthalmology Annual Meeting, Fort Lauderdale, FL, 5/1/2012

Lectures

• Results of the Age-Related Eye Disease Study 2 (AREDS2). 
  Warren, OH - 9/10/2013
• Retinal update on anti-VEGF therapy (with Drs. Coney, Miller, Rao, Schartman, and Zegarra). 
  Vermilion, OH - 12/20/2012
• Lifestyle modifications to prevent the development & progression of macular degeneration. 
  Case Western Reserve University School of Medicine, Cleveland, OH - 11/8/2012
• Update of lifestyle modifications to treat patients with macular degeneration. 
  Youngstown, OH - 9/20/2012
• Retinal update on anti-VEGF therapy. 
  Vermilion, OH - 8/12/2012
• Posterior segment manifestations of ocular worm infestations. 
  Beachwood, OH - 3/15/2012
• Recent advances in the treatment of diabetic macular edema. 
  Cleveland, OH - 10/12/2010
• Advances in the treatment of diabetic macular edema. 
  Westlake, OH - 8/19/2010
• A patient’s experience with a retinal specialist. 
  Lorain, OH - 1/13/2009
• Update on lifestyle and dietary modifications for patients with age-related macular degeneration (AMD). 
  Youngstown, OH - 9/18/2008
• Interesting retinal cases. 
  Westlake, OH - 6/18/2008
• Interesting vitreoretinal cases. 
  Beachwood, OH - 2/21/2008
• Rhegmatogenous retinal detachment. 
  Youngstown, OH - 9/5/2007
• Modern treatment of rhegmatogenous retinal detachment. 
  Beachwood, OH - 2/15/2007
• Update on lifestyle and dietary modifications for patients with age-related macular degeneration. 
  Youngstown, OH - 9/28/2006
• Lifestyle and for people with age-related macular degeneration. 
  Solon, OH - 6/3/2006
• Retinal detachment. 
  Parma, OH - 3/21/2006
• Lifestyle and dietary modifications for patients with age-related macular degeneration. 
  Beachwood, OH - 2/9/2006
• Nutrition and dietary modifications - can what I eat affect macular degeneration? 
  Middleburg Heights, OH - 10/29/2005
• Complications of vitrectomy. 
  Cleveland, OH - 10/11/2005
• An overview of macular degeneration. 
  Westlake, OH - 8/11/2005
• Macular degeneration. 
  Lakewood, OH - 4/1/2005
• Lifestyle & dietary modifications for patients with age-related macular degeneration. 
  Beachwood, OH - 2/15/2005
• Pre-Academy Fluorescein Angiography Club. (1985-2005) 
  1/1/2005
• Infectious endophthalmitis. 
  Parma, OH - 10/5/2004
• Join now to see all